148 related articles for article (PubMed ID: 20663964)
1. Effect of repetitive arm cycling following botulinum toxin injection for poststroke spasticity: evidence from FMRI.
Diserens K; Ruegg D; Kleiser R; Hyde S; Perret N; Vuadens P; Fornari E; Vingerhoets F; Seitz RJ
Neurorehabil Neural Repair; 2010 Oct; 24(8):753-62. PubMed ID: 20663964
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
[TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with botulinum toxin injections against spasticity in children].
Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injection of the subscapularis muscle.
Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
9. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke.
Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P
J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958
[TBL] [Abstract][Full Text] [Related]
10. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
[TBL] [Abstract][Full Text] [Related]
11. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
Cousins E; Ward A; Roffe C; Rimington L; Pandyan A
Clin Rehabil; 2010 Jun; 24(6):501-13. PubMed ID: 20483887
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
[TBL] [Abstract][Full Text] [Related]
13. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
[TBL] [Abstract][Full Text] [Related]
14. Motor control testing of upper limb function after botulinum toxin injection: a case study.
Hurvitz EA; Conti GE; Flansburg EL; Brown SH
Arch Phys Med Rehabil; 2000 Oct; 81(10):1408-15. PubMed ID: 11030508
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke.
Ameli M; Grefkes C; Kemper F; Riegg FP; Rehme AK; Karbe H; Fink GR; Nowak DA
Ann Neurol; 2009 Sep; 66(3):298-309. PubMed ID: 19798637
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
Bensmail D; Robertson JV; Fermanian C; Roby-Brami A
Neurorehabil Neural Repair; 2010; 24(3):273-81. PubMed ID: 20067949
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
Yablon SA
Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
[TBL] [Abstract][Full Text] [Related]
20. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
Rousseaux M; Compère S; Launay MJ; Kozlowski O
J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
